» Articles » PMID: 36160626

Radiological Review of Rhinocerebral Mucormycosis Cases During the COVID-19 Pandemic: A Single-center Experience

Overview
Journal World J Radiol
Specialty Radiology
Date 2022 Sep 26
PMID 36160626
Authors
Affiliations
Soon will be listed here.
Abstract

Mucormycosis is caused by the fungi belonging to the order and class The incidence of mucormycosis has increased with the onset of the severe acute respiratory syndrome coronavirus 2 infections leading to the coronavirus disease 2019 (COVID-19) pandemic. This rise is attributed to the use of immunosuppressive medication to treat COVID-19 infections. Authors have retrospectively collected data of our cases of mucormycosis diagnosed from April 2020 to April 2021 at our institute. A total of 20 patients with rhinocerebral mucormycosis were studied. Most of the study subjects were male patients (90%) and were of the age group 41-50 years. Most patients in the review had comorbidities (85%) with diabetes being the most common comorbidity. Para nasal sinuses were involved in all the cases. Involvement of the neck spaces was present in 60% of the cases. Involvement of the central nervous system was present in 80% of the cases. Orbital involvement was present in 90% of the cases. The authors reviewed the various imaging findings of mucormycosis on computed tomography and magnetic resonance imaging in this article.

Citing Articles

Rise of mucormycosis during the COVID-19 pandemic and the challenges faced.

Kottarathil M, Thayanidhi P, P S, Kindo A Curr Med Mycol. 2023; 9(1):44-55.

PMID: 37867589 PMC: 10590187. DOI: 10.18502/cmm.2023.345032.1400.


Spectrum of magnetic resonance imaging findings in post-COVID-19 patients presenting with rhino-orbito-cerebral mucormycosis in a teaching hospital in Malwa region of Punjab.

Singh P, Kaur K, Jindal V, Kaur M, Kaur M, Singh N J Family Med Prim Care. 2023; 11(12):7788-7794.

PMID: 36994047 PMC: 10041016. DOI: 10.4103/jfmpc.jfmpc_1136_22.

References
1.
Hoenigl M, Seidel D, Carvalho A, Rudramurthy S, Arastehfar A, Gangneux J . The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries. Lancet Microbe. 2022; 3(7):e543-e552. PMC: 8789240. DOI: 10.1016/S2666-5247(21)00237-8. View

2.
SILVERMAN C, Mancuso A . Periantral soft-tissue infiltration and its relevance to the early detection of invasive fungal sinusitis: CT and MR findings. AJNR Am J Neuroradiol. 1998; 19(2):321-5. PMC: 8338170. View

3.
Ibrahim A, Spellberg B, Walsh T, Kontoyiannis D . Pathogenesis of mucormycosis. Clin Infect Dis. 2012; 54 Suppl 1:S16-22. PMC: 3286196. DOI: 10.1093/cid/cir865. View

4.
Al-Tawfiq J, Alhumaid S, Alshukairi A, Temsah M, Barry M, Mutair A . COVID-19 and mucormycosis superinfection: the perfect storm. Infection. 2021; 49(5):833-853. PMC: 8302461. DOI: 10.1007/s15010-021-01670-1. View

5.
Gillespie M, Huchton D, OMalley B . Role of middle turbinate biopsy in the diagnosis of fulminant invasive fungal rhinosinusitis. Laryngoscope. 2000; 110(11):1832-6. DOI: 10.1097/00005537-200011000-00013. View